InsiderClue
Stocks · Health care · Services-Medical Laboratories

BioNexus Gene Lab Corp

BGLC Clue Score27
United States Fiscal year ends December CIK 0001737523
$1.29 +3.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.29 +9.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Sep 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue0.2Operating income0.1Net income0.0Fiscal year 2019Revenue0.1 −40.2%Operating income−0.3Net income−0.2 −1,031.7%Fiscal year 2020Revenue11.4 +8,872.0%Operating income1.3Net income1.1Fiscal year 2021Revenue13.4 +17.3%Operating income1.1Net income0.8 −31.3%Fiscal year 2022Revenue10.9 −18.2%Operating income−0.3Net income−0.4 −147.4%Fiscal year 2023Revenue9.8 −10.6%Operating income−2.6Net income−2.6EPS, diluted−0.17Fiscal year 2024Revenue9.5 −2.7%Operating income−1.6Net income−1.6EPS, diluted−0.09Fiscal year 2025Revenue7.4 −21.9%Operating income−3.0Net income−3.0
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.1 11.4 13.4 10.9 9.8 9.5 7.4
Growth −40.2% +8,872.0% +17.3% −18.2% −10.6% −2.7% −21.9%
Operating income 0.1 −0.3 1.3 1.1 −0.3 −2.6 −1.6 −3.0
Net income 0.0 −0.2 1.1 0.8 −0.4 −2.6 −1.6 −3.0
Growth −1,031.7% −31.3% −147.4%
EPS, diluted n/a n/a n/a n/a n/a −0.17 −0.09 n/a
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2018Gross margin13.5%Operating margin28.2%Net margin12.5%Free cash flow margin−110.4%Fiscal year 2019Gross margin44.0%Operating margin−217.2%Net margin−194.1%Free cash flow margin−181.2%Fiscal year 2020Gross margin15.1%Operating margin11.2%Net margin9.6%Free cash flow margin1.2%Fiscal year 2021Gross margin17.0%Operating margin7.9%Net margin5.6%Free cash flow margin0.0%Fiscal year 2022Gross margin11.5%Operating margin−2.7%Net margin−3.3%Free cash flow margin5.0%Fiscal year 2023Gross margin13.6%Operating margin−26.5%Net margin−26.9%Free cash flow margin−20.2%Fiscal year 2024Gross margin13.6%Operating margin−16.5%Net margin−16.8%Free cash flow margin−24.4%Fiscal year 2025Gross margin14.6%Operating margin−39.9%Net margin−40.2%Free cash flow margin−25.3%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 13.5% 44.0% 15.1% 17.0% 11.5% 13.6% 13.6% 14.6%
Operating margin 28.2% −217.2% 11.2% 7.9% −2.7% −26.5% −16.5% −39.9%
Net margin 12.5% −194.1% 9.6% 5.6% −3.3% −26.9% −16.8% −40.2%
Free cash flow margin −110.4% −181.2% 1.2% 0.0% 5.0% −20.2% −24.4% −25.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−0.3Capital expenditure0.0Free cash flow−0.2Fiscal year 2019Operating cash flow−0.2Capital expenditure−0.0Free cash flow−0.2Fiscal year 2020Operating cash flow0.6Capital expenditure−0.4Free cash flow0.1Fiscal year 2021Operating cash flow0.0Capital expenditure−0.0Free cash flow0.0 −95.4%Fiscal year 2022Operating cash flow0.6Capital expenditure0.0Free cash flow0.6 +9,098.6%Fiscal year 2023Operating cash flow−1.8Capital expenditure−0.1Free cash flow−2.0 −457.3%Fiscal year 2024Operating cash flow−2.1Capital expenditure−0.2Free cash flow−2.3Fiscal year 2025Operating cash flow−1.8Capital expenditure−0.0Free cash flow−1.9
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.3 −0.2 0.6 0.0 0.6 −1.8 −2.1 −1.8
Capital expenditure 0.0 −0.0 −0.4 −0.0 0.0 −0.1 −0.2 −0.0
Free cash flow −0.2 −0.2 0.1 0.0 0.6 −2.0 −2.3 −1.9
Growth −95.4% +9,098.6% −457.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2018Cash1.3Shareholders’ equity1.5Fiscal year 2019Cash0.9Shareholders’ equity1.1Fiscal year 2020Cash2.8Shareholders’ equity6.7Fiscal year 2021Cash2.1Shareholders’ equity7.2Fiscal year 2022Cash2.1Shareholders’ equity6.7Fiscal year 2023Cash4.5Shareholders’ equity9.7Fiscal year 2024Cash2.9Shareholders’ equity8.3Fiscal year 2025Cash2.5Shareholders’ equity8.6
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.3 0.9 2.8 2.1 2.1 4.5 2.9 2.5
Shareholders’ equity 1.5 1.1 6.7 7.2 6.7 9.7 8.3 8.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−0.3 −0.2 0.6 0.0 0.6 −1.8 −2.1 −1.8
Growth −98.3% +5,923.6% −430.2%
Investment
0.0 −0.0 −0.4 −0.0 0.0 −0.1 −0.2 −0.0
calc −0.2 −0.2 0.1 0.0 0.6 −2.0 −2.3 −1.9
Growth −95.4% +9,098.6% −457.3%
calc n/a n/a n/a n/a n/a −0.12 −0.13 n/a
−0.1 −0.0 1.3 −0.5 −0.5 −1.8 0.4 0.9
Financing
0.7 −0.2 −0.0 −0.0 0.1 6.3 0.0 0.3

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.